Cambridge coronavirus vaccine candidate trials could begin in the autumn
The research has been given a £1.9 million funding boost from Innovate UK.
The research has been given a £1.9 million funding boost from Innovate UK.
Scientists found the RNA vaccine was generally well-tolerated, although some participants experienced mild to moderate side-effects.
POSSIBLE Covid-19 candidate vaccines for the Bailiwick have been set out by Public Health director Dr Nicola Brink.
Royal Navy abolished the daily ration of rum for sailors on July 31 1970.
Pre-clinical studies suggest the vaccine produces highly specific antibodies against the virus in mice.
Dr Katrina Pollock, from Imperial College London, said it was ‘too early’ to speculate whether the vaccine candidate will prevent infection.
The Wildlife Disease Surveillance Focus Group said the lack of screening for disease-causing organisms in the wildlife trade is concerning.
A number of Covid-19 vaccines are being trialled in humans, with companies committing to manufacture doses at scale.
Imperial’s candidate is the second of the two potential vaccines being trialled in the UK.
The RT-LAMP technique is thought to be less expensive than the standard PCR testing currently being used.
It is not currently known how long coronavirus immunity lasts.
The vaccine is now due to enter phase one and two human clinical trials on June 15 with 300 people.
Downing Street said officials were investigating whether sewage samples would allow them to track the virus.
Communities Secretary Robert Jenrick said a ‘broader’ slogan is needed as the Government tries to restart the economy.
Scientists at the University of Glasgow analysed samples of SARS-CoV-2, the virus that causes Covid-19.